Explore

Healthy Living

News

Health A-Z

Calculators

Articles

Drugs

Directories

Education

More

Search Medindia

Medindia » Health Tips » FDA Approved C1 Esterase Inhibitor (Human) for Hereditary Angioedema

FDA Approved C1 Esterase Inhibitor (Human) for Hereditary Angioedema

Hereditary angioedema is a rare genetic disorder in which the patient suffers from attacks of swelling of the tissues just below the skin and mucous membranes in several parts of the body including the face, abdomen and limbs. The number of attacks, the severity of the attacks and the sites affected vary from person to person.

FDA Approved C1 Esterase Inhibitor (Human) for Hereditary Angioedema

FDA Approved C1 Esterase Inhibitor (Human) for Hereditary Angioedema

A C1-esterase inhibitor (human) has been approved by the FDA for the prevention of attacks of hereditary angioedema.

Health Centers Specialty Health Quotes

Recommended Reading

Angioedema - Causes, Symptoms, Diagnosis & Treatment

Angioedema - Causes, Symptoms, Diagnosis & Treatment

Angioedema is a condition that causes leakage of blood vessels resulting in the swelling of deeper layers of the skin, subcutaneous and submucosal tissues.

Are There Effective Treatments For Hereditary Angioedema In Children

Are There Effective Treatments For Hereditary Angioedema In Children

A comprehensive review of the therapies currently available to treat HAE in adults shows that some of these treatments are also safe and effective for use in older children and adolescents.

Danazol

<br>This medication is a synthetic steroid, prescribed for endometriosis and hereditary angioedema.

Clinical Trials Show New Drug is Safe, Effective in Treating Hereditary Angioedema

Clinical Trials Show New Drug is Safe, Effective in Treating Hereditary Angioedema

Clinical trials from two international research teams have shown that icatibant, a new drug that blocks the action of an inflammatory protein known as bradykinin, is safe and effective

Health Tips

More...

Health Tips - Specialty

More...

⬆️